PetLife Pharmaceuticals, Inc.
company.status.inactiveCIK 1354591fmd_0Z6ZTK5G4BCA7BKRZG1PY446YKManufacturing · Industrial Organic ChemicalsTemplate: Standard
Coverage: Sep 01, 2010 to Feb 28, 2018, 29 periods
Latest annual · FY2014
Millions- Total revenues
- 0
- Operating income
- (23)
- Net income
- (23)
Latest quarter · Q2 FY2018
Millions- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2012 to FY2017
- n/m
PetLife Pharmaceuticals, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Operating income | -$22.7 million | -$3.7 million | 10-K 2017-12-15 · proof | |
| Net income | -$23.3 million | -$3.7 million | 10-K 2017-12-15 · proof | |
| Cash from operating activities | -$318,918 | -$151,839 | 10-K 2017-12-15 · proof | |
| Total assets | $55,004 | $1,172 | +4,593.2% | 10-K 2017-12-15 · proof |
| Total liabilities | $1.4 million | $3.2 million | -55.6% | 10-K 2017-12-15 · proof |
| Cash and cash equivalents | $54,254 | $1,172 | +4,529.2% | 10-K 2017-12-15 · proof |
- What was PetLife Pharmaceuticals, Inc.'s operating income in fiscal 2017?
- PetLife Pharmaceuticals, Inc. reported operating income of -$22.7 million for fiscal 2017 (the year ended Aug 31, 2017), against -$3.7 million the year before. Source: the 10-K filed with the SEC on Dec 15, 2017. SEC
- What was PetLife Pharmaceuticals, Inc.'s net income in fiscal 2017?
- PetLife Pharmaceuticals, Inc. reported net income of -$23.3 million for fiscal 2017 (the year ended Aug 31, 2017), against -$3.7 million the year before. Source: the 10-K filed with the SEC on Dec 15, 2017. SEC
- What was PetLife Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2017?
- PetLife Pharmaceuticals, Inc. reported cash from operating activities of -$318,918 for fiscal 2017 (the year ended Aug 31, 2017), against -$151,839 the year before. Source: the 10-K filed with the SEC on Dec 15, 2017. SEC
- What are PetLife Pharmaceuticals, Inc.'s total assets?
- As of Aug 31, 2017, PetLife Pharmaceuticals, Inc. reported total assets of $55,004, against $1,172 a year earlier (+4,593.2%). Source: the 10-K filed with the SEC on Dec 15, 2017. SEC
- What are PetLife Pharmaceuticals, Inc.'s total liabilities?
- As of Aug 31, 2017, PetLife Pharmaceuticals, Inc. reported total liabilities of $1.4 million, against $3.2 million a year earlier (-55.6%). Source: the 10-K filed with the SEC on Dec 15, 2017. SEC
- What are PetLife Pharmaceuticals, Inc.'s cash and cash equivalents?
- As of Aug 31, 2017, PetLife Pharmaceuticals, Inc. reported cash and cash equivalents of $54,254, against $1,172 a year earlier (+4,529.2%). Source: the 10-K filed with the SEC on Dec 15, 2017. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1354591&period_type=annual&limit=5"Information only, not investment advice.